about
Plant Alkaloids as Antiplatelet Agent: Drugs of the Future in the Light of Recent DevelopmentsBiological Evaluation and Docking Analysis of Daturaolone as Potential Cyclooxygenase InhibitorAntidepressant potential of peptides: New insights as future therapeutic.Potential of Plant Alkaloids as Antipyretic Drugs of Future.Anti-tumour-promoting and thermal-induced protein denaturation inhibitory activities of β-sitosterol and lupeol isolated from Diospyros lotus L.Antifungal Potential of Alkaloids as An Emerging Therapeutic Target.Phyto-glycosides as therapeutic target in the treatment of diabetes.A holistic review on the autoimmune disease vitiligo with emphasis on the causal factors.Pharmacological and Toxicological profile of harmane-β-Carboline alkaloid: Friend or foe.Evidence Based Alternative Medicines in Pain Management 2016.Bioassay-guided isolation of antibacterial constituents from Diospyros lotus roots.Evidence Based Alternative Medicines in Pain ManagementTherapeutic potential of songorine, a diterpenoid alkaloid of the genus Aconitum.The relevance of folkloric usage of plant galls as medicines: Finding the scientific rationale.Apigenin as neuroprotective agent: Of mice and men.In vivo and in silico sedative-hypnotic like activity of 7-methyljuglone isolated from Diospyros lotus L.Sedative-hypnotic-like effect and molecular docking of di-naphthodiospyrol from Diospyros lotus in an animal model.Targeting BDNF modulation by plant glycosides as a novel therapeutic strategy in the treatment of depression.Antiplatelet potential of plant-derived glycosides as possible lead compounds.Evidence and prospective of plant derived flavonoids as antiplatelet agents: Strong candidates to be drugs of future.Phytochemical analysis, antibacterial, and antifungal assessment of aerial parts of Polygonatum verticillatum.Plant-derived mPGES-1 inhibitors or suppressors: A new emerging trend in the search for small molecules to combat inflammation.Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects.In-silico Studies of Isolated Phytoalkaloid Against Lipoxygenase: Study Based on Possible Correlation.Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies.Emerging CAM Ziziphus nummularia with in vivo sedative-hypnotic, antipyretic and analgesic attributes.An Overview on Citrus aurantium L.: Its Functions as Food Ingredient and Therapeutic Agent.Natural Products as an Emerging Therapeutic Alternative in the Treatment of Neurological Disorders.Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing.Role of vitamin D and vitamin D receptor (VDR) in oral cancerPotent in Vitro α-Glucosidase Inhibition of Secondary Metabolites Derived fromMedicinal Plants in Light of History: Recognized Therapeutic ModalityElucidation of Phosphodiesterase-1 Inhibitory Effect of Some Selected Natural Polyphenolics Using In Vitro and In Silico MethodsGlycosides from Medicinal Plants as Potential Anticancer Agents: Emerging Trends Towards Future DrugsCurrent standing of plant derived flavonoids as an antidepressantAnti-inflammatory effects of Melatonin: A mechanistic reviewDiverse Therapeutic Potential of Nitidine, A Comprehensive ReviewThe analgesic potential of glycosides derived from medicinal plantsResveratrol in Autism Spectrum Disorders: Behavioral and Molecular EffectsAnti-cancer effects of polyphenols via targeting p53 signaling pathway: updates and future directions
P50
Q28076248-0815A47C-E41E-4206-8B24-CF6687173755Q36690580-749D5AEA-B17E-4321-AB93-27DA675E4F34Q38649448-E9CFBD85-2A3B-434D-89EF-A9BF2333F806Q38769693-C54C258F-5C83-40E1-85D8-1F74FECFCBB4Q38857722-F8CC2C3B-BE07-4F76-9EE5-EA2E401E2684Q38903755-9C0A356B-D80E-405E-8340-792A5FDA8048Q38954784-D62140FE-A85D-4535-B585-7CAA3AB2D33DQ39346579-D8862096-1BF8-4CD6-A8E3-04F86E0F8803Q39360024-50C8B8B1-BD65-417F-8979-E0B36F5D7FEAQ41266548-2CC3165C-1F5C-4272-AB20-90884BB42520Q41471401-42E604E6-2D72-4382-895A-339357448C60Q42594257-F9D09447-27E2-4F89-8204-FA1202A43161Q46262498-C9167E47-B777-4E4E-BB62-959063D45270Q46270759-D3D633FE-B5FC-43BC-99B7-D78396F812A0Q46278430-C8C9497F-8EB6-4F01-9360-F970736B508EQ46516359-75E1FD37-ACB5-4544-9B49-22C2B247DCCBQ46722605-90900BF8-F09D-416C-A2BF-0562CDEBDE82Q47653580-F578DF0B-FE35-4475-9DC6-4C11FD84654BQ48020392-E0DEAE87-2EC0-4CAE-87FF-B6CD846C0CC8Q49968428-CAC475AD-E952-4628-909F-6AAD717F73DBQ50005008-DF007760-3CEA-443B-9B92-8771AD03B7B4Q50061085-E529F9B2-B2B8-4843-B1E5-D2C77D7BBF7BQ52595757-3A3E558A-EE9B-4302-840E-76201057FDAAQ52690862-0C1481E9-D430-4F9F-AF6B-4B66BEDC7747Q53127689-35B2F9AE-A6EC-4704-95B6-4D92E4CBE4D0Q55058493-21368A61-B30E-45B4-9D6E-A55E25232DE4Q55254011-9C3DA0EC-49DF-45E3-B3D0-ED86ED1E7363Q55334490-731AD3EA-BCB6-49CA-849D-8C0A3B5DA72DQ55360734-BF9C4DD1-E7AF-4570-B0D7-AD374DC7DCF3Q58613585-ED0E6383-F42C-4475-9700-14E9F6F84CBCQ64269200-85CEFA98-4C88-4A2B-9438-9BD872E1FA9AQ87798034-137096EB-9A82-485F-89DD-D45595FEBF6CQ88196883-4EF41242-D4CA-4AE9-BA4C-D04B1B5BEEEEQ88252156-AEE40DE4-241B-4E2C-BF0C-8105F7BD81B3Q88500370-73BEEA66-064F-4C98-B88B-51D9A56D3580Q89102789-777919D2-AD54-4249-9457-6BE7AB3AA6E4Q89341075-CF7373A4-1601-47E9-A27E-AF99263BCEC5Q89724556-6C9F4A3C-EFD3-402A-9316-C7F6E3939AE0Q89920293-7EC9C944-CF91-4954-91D5-45DEA8A0973EQ90030310-B7DBDD62-B29F-44F4-BB6C-DE14AF65CACD
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Haroon Khan
@en
Haroon Khan
@nl
type
label
Haroon Khan
@en
Haroon Khan
@nl
prefLabel
Haroon Khan
@en
Haroon Khan
@nl
P31
P496
0000-0002-1736-4404